Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma – August 15, 2024

Webinars

The Lymphoma Research Foundation’s free webinars are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials, and promising innovative research. Webinars can be listened to live on the telephone or via web streaming.

Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma

DATE: Thursday, August 15, 2024
TIME: 1:00 PM – 2:00 PM Eastern Time

VIRTUAL PROGRAM – This is a Zoom virtual event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Look for Zoom as sender of confirmation and reminder emails.

Featuring

Tatyana Feldman, MD
Hematologist and Oncologist
Director, T-Cell Lymphoma Program
Hackensack University Medical Center

Program Overview

  • Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
  • Considering Second- and Third-Line Treatment Options
  • Update on Clinical Trials
  • Question and Answer Session

Ways to Register

VIRTUAL PROGRAM – This is a Zoom virtual event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio. Note: Zoom will email confirmation and reminders.

Call: 800-500-9976
Email: helpline@lymphoma.org

This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email vgonzalez@lymphoma.org to learn more about sponsorship.

Disclaimer: The Lymphoma Research Foundation is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, we recommend the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from: